Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

14.18 -1.42 (-9.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
These Analysts Boost Their Forecasts On Liquidia
Via Benzinga
Breaking Down Liquidia: 12 Analysts Share Their Views
Via Benzinga
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
Breaking Down Liquidia: 4 Analysts Share Their Views
Via Benzinga
The Analyst Landscape: 11 Takes On Liquidia
Via Benzinga
Liquidia Scores FDA Nod For Lung Disease Drug Yutrepia, Faces Legal Challenge
Liquidia gains FDA approval for Yutrepia to treat PAH and PH-ILD, with funding in place despite ongoing patent litigation with United Therapeutics 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Liquidia Retail Buzz Surges After BofA Raises Price Target to $25 On Yutrepia FDA Nod
The company’s proprietary dry-powder formulation, supported by Phase 3 data, is viewed as a promising alternative to United Therapeutics’ Tyvaso, though legal challenges remain pending. 
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property Product Safety
U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Technologies, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Where Liquidia Stands With Analysts
Via Benzinga
Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
From Liquidia Corporation
Via GlobeNewswire
Breaking Down Liquidia: 4 Analysts Share Their Views
Via Benzinga
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
FDA sets PDUFA goal date of May 24, 2025 
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
From Liquidia Corporation
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Liquidia
Via Benzinga
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Earnings Scheduled For March 19, 2025
Via Benzinga
Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
From Liquidia Corporation
Via GlobeNewswire
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
From Atea Pharmaceuticals, Inc.
Via GlobeNewswire
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.